Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Crohn Disease × secukinumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Psoriasis 1 Periodic Fevers Syndrome 1 Motor Activity 1 Lymphoma, Follicular 1 Crohn Disease 1 Arthritis, Rheumatoid 1

Interventions

Certolizumab Pegol 5 MEDI2070 2 Infliximab 2 Adalimumab 2 secukinumab 1 golimumab 1 Ustekinumab 1 CT-P13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584740 2015-03-31

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Novartis

Phase 2 Terminated

59 enrolled 13 charts

Crohn Disease, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡